Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Krista F.g. Huybrechts, Ph.D.

Co-Author

This page shows the publications co-authored by Krista Huybrechts and Jessica Franklin.
Connection Strength

2.415
  1. Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One. 2011 Apr 06; 6(4):e18210.
    View in: PubMed
    Score: 0.232
  2. Evaluating the Utility of Coarsened Exact Matching for Pharmacoepidemiology Using Real and Simulated Claims Data. Am J Epidemiol. 2020 06 01; 189(6):613-622.
    View in: PubMed
    Score: 0.219
  3. Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care. Circ Cardiovasc Qual Outcomes. 2019 02; 12(2):e005173.
    View in: PubMed
    Score: 0.200
  4. Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records. Clin Pharmacol Ther. 2019 04; 105(4):979-993.
    View in: PubMed
    Score: 0.197
  5. Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology. Am J Epidemiol. 2018 09 01; 187(9):1951-1961.
    View in: PubMed
    Score: 0.194
  6. A Bias in the Evaluation of Bias Comparing Randomized Trials with Nonexperimental Studies. Epidemiol Methods. 2017 Apr; 6(1).
    View in: PubMed
    Score: 0.177
  7. Statins and congenital malformations: cohort study. BMJ. 2015 Mar 17; 350:h1035.
    View in: PubMed
    Score: 0.153
  8. Antipsychotics and mortality: adjusting for mortality risk scores to address confounding by terminal illness. J Am Geriatr Soc. 2015 Mar; 63(3):516-23.
    View in: PubMed
    Score: 0.152
  9. Evaluating possible confounding by prescriber in comparative effectiveness research. Epidemiology. 2015 Mar; 26(2):238-41.
    View in: PubMed
    Score: 0.152
  10. Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med. 2014 Jun 19; 370(25):2397-407.
    View in: PubMed
    Score: 0.145
  11. Instrumental variable applications using nursing home prescribing preferences in comparative effectiveness research. Pharmacoepidemiol Drug Saf. 2014 Aug; 23(8):830-8.
    View in: PubMed
    Score: 0.143
  12. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 01; 174(11):1213-22.
    View in: PubMed
    Score: 0.060
  13. Prescription opioid use after vaginal delivery and subsequent persistent opioid use and misuse. Am J Obstet Gynecol MFM. 2021 03; 3(2):100304.
    View in: PubMed
    Score: 0.057
  14. Predicting overdose among individuals prescribed opioids using routinely collected healthcare utilization data. PLoS One. 2020; 15(10):e0241083.
    View in: PubMed
    Score: 0.056
  15. Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions. J Gen Intern Med. 2019 11; 34(11):2339-2341.
    View in: PubMed
    Score: 0.053
  16. Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - United States, 2014. MMWR Morb Mortal Wkly Rep. 2019 Feb 15; 68(6):140-143.
    View in: PubMed
    Score: 0.050
  17. Changes in Outpatient Use of Antibiotics by Adults in the United States, 2006-2015. Drug Saf. 2018 12; 41(12):1333-1342.
    View in: PubMed
    Score: 0.049
  18. Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):383-390.
    View in: PubMed
    Score: 0.047
  19. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naïve women. Am J Obstet Gynecol. 2016 09; 215(3):353.e1-353.e18.
    View in: PubMed
    Score: 0.041
  20. Chronic hypertension in pregnancy and the risk of congenital malformations: a cohort study. Am J Obstet Gynecol. 2015 Mar; 212(3):337.e1-14.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.